Jack K. Sharp, M.D., C.M.
Affiliations: | 2016 | Duke University, Durham, NC | |
| 2016- | Texas Children's Hospital, Houston, United States |
Google:
"Jack Sharp"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Voynow JA, Fisher K, Sunday ME, et al. (2020) Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. Pediatric Pulmonology |
| Kay DM, Langfelder-Schwind E, DeCelie-Germana J, et al. (2015) Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening. Pediatric Pulmonology. 50: 771-80 |
| Rock MJ, Sharp JK. (2010) Cystic fibrosis and CRMS screening: what the primary care pediatrician should know. Pediatric Annals. 39: 759-68 |
| Borowitz D, Parad RB, et al. (2009) Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. The Journal of Pediatrics. 155: S106-16 |
| Sharp JK, Rock MJ. (2008) Newborn screening for cystic fibrosis. Clinical Reviews in Allergy & Immunology. 35: 107-15 |
| Sharp JK. (2002) Monitoring early inflammation in CF. Infant pulmonary function testing. Clinical Reviews in Allergy & Immunology. 23: 59-76 |